Great Valley Advisor Group, Inc. Gilead Sciences, Inc. Transaction History
Great Valley Advisor Group, Inc.
- $4.08 Billion
- Q2 2025
A detailed history of Great Valley Advisor Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 5,196 shares of GILD stock, worth $614,686. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,196
Previous 5,993
13.3%
Holding current value
$614,686
Previous $671,000
14.16%
% of portfolio
0.01%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
2,329Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.13M-
Black Rock Inc. New York, NY121MShares$14.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.2MShares$7 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.48 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.44 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $148B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...